Peptides, Lipids & Carbs
Definitely Potent & Oncology
Full-Service, Fully Committed
CordenPharma, the worldwide pharmaceutical solution & production platform of Overseas Chemical Investors Group (ICIG), is just a full-service Contract Development & production Organization (CDMO) for the creation of APIs, Drug Products, and linked Packaging Services. Through a growing system of concentrated investments across European countries as well as the United States arranged under Technology Platforms, CordenPharma experts translate complex processes, a few ideas and tasks at any phase of development into high-value items.
Active Pharmaceutical Ingredients
Pharma Packaging& Logistics
CordenPharmaвЂ™s supply that is vertically-integrated model provides development & production expertise spanning the entire cGMP supply chain > from regulated recycleables through intermediates, APIs, commercial-scale Drug Product manufacturing, completed dosage formula, packaging, medical test solutions, & pharma logistics > resulting in paid down development & production some time expense.
Information & Press
CDMO Expands US Peptide Production Capability
Molecule to promote Podcast: A CDMO from the frontline
LIVE WEBINAR > Your Injectable Roadmap for Combined Drug Product-Device Regulations & Capabilities when you look at the New Normal
TUES OCT 13 at 16:00 CEST / 10:00 EDT > ENTER HERE
Sign up to our Publication
Remain as much as date because of the latest idea leadership articles and news from CordenPharma.
TIDES VIRTUAL 2020 > Sept 15-18
Sept 7 – 9, 2020
David Intercontinental Tel Aviv, Israel Event site
CPhI united states
Sept 9 – 11, 2020
Pennsylvania Convention Center Philadelphia, PA United States Of America Event internet site
September 14 – 15, 2020
Ocean Put Resort Long Branch, NJ USA Event site
Browse our collection of Brochures, Product Lists, White Papers, Videos & Webinars.
Put an inquiry right here > one of y our group of specialists are certain to get back again to you.
В©2020 CordenPharma Global
Dr. Lee Newton Chief Working Officer, CordenPharma
Dr. Lee Newton joins CordenPharma from Lonza, where he of late held the part of Senior Vice President & Business Unit Head for LonzaвЂ™s Small Molecule API company. Lee has over twenty years of expertise inside the Pharmaceutical Industry. After starting their profession in primary production with GlaxoWellcome, Lee moved to the CDMO sector in 2002 with Avecia, and it has since worked in several operational & commercial functions with increasing obligation including as Operations Director for Carbogen Amcis. A PhD is held by him in Organic Chemistry through the University of Heriot-Watt (UK). Lee is Scottish nationwide presently surviving in Switzerland.
William Cashin Chief Quality & Compliance Officer, CordenPharma
William Cashin joined CordenPharma as Chief Quality & Compliance Officer in might 2020. Will joins us from Lonza, where he served as international mind Quality, Mammalian and Microbial. In this part, he had been directly in charge of every aspect of quality for biopharmaceutical worldwide production operations within European countries, the united states, Singapore and Asia. Ahead of that, Will worked extensively within the industry that is pharmaceutical including functions of increasing duty at Alexion, GSK and Pfizer. A BachelorвЂ™s is held by him level in Applied Chemistry through the Waterford Institute of tech in Ireland and a MasterвЂ™s level in operation management through the Open University, (UK). William can be an Irish nationwide, currently located in Switzerland.
Just click here to see us of any questions that are urgent issues. CEO Movie Modify
Dr. Walter Kittl Interim Managing Director, CordenPharma Plankstadt
Dr. Walter Kittl could be the Interim Managing Director, CordenPharma Plankstadt, beginning March 19, 2020. With more than 35 several years of experience with the pharmaceutical, CMO and fine chemical companies, Walter brings a holistic knowledge of pharmaceutical production operations caused by a multi-faceted profession starting as being a venture Manager in R&D and manufacturing at DSM Fine Chemicals. Walter then held different senior administration roles with increasing amounts of obligation at Roche, where he became Site Manager associated with Basel Chemical production web web site, and Siegfried AG, where he had been President & General Manager of Siegfried USA before becoming your head of Global Technical Operations. Walter is definitely a citizen that is austrian holds a Ph.D. in Chemistry through the Leopold-Franzens University of Innsbruck, Austria.
Benis Cehic Managing Director, CordenPharma Plankstadt
Benis Cehic joined up with CordenPharma as Managing Director, CordenPharma Plankstadt in 2020 january. Ahead of joining CordenPharma, Benis held different senior jobs when you look at the industry that is pharmaceutical over ten years of expertise. Benis Cehic began their job in the pharmaceutical Company KRKA, d.d., Slovenia, where he had been in charge of commercial manufacturing of APIs including particular transfers to CMOs and scale-ups of technologies. Since 2013, Benis held various senior roles at BAYER HealthCare and Animal Health within the aspects of worldwide exterior Manufacturing, and much more recently within BAYERВґs worldwide provide Center of finished items in Kiel, Germany, where he held executive that is distinct leadership jobs with increasing obligation, including overseeing technology transfers and life-cycle administration. He had been accountable and accountable for the procedure product solids in formula and packaging of pills, also leading your website engineering group. Additionally, Benis had been a deputy Director that is managing at provide Center Kiel. He holds a Chemical Engineering level from University of Ljubljana, Slovenia in which he complemented additional courses to his studies such as for instance Lean Professional and Executive company & Management studies in the ESADE company class in Barcelona, Spain.
Jason Bertola Director, Worldwide Definitely Potent & Oncology System, CordenPharma Global
Jason Bertola joined up with CordenPharma in 2016 as Director, worldwide Highly Potent & Oncology system, CordenPharma Overseas. Jason started their job in pharmaceutical process development first with SAPEC (now Cerbios) and then Hoffmann-La Roche before transitioning into company development and product product product sales. He brings over 27 years of diverse leadership expertise in the pharmaceutical industry with substantial expertise in agreement development and manufacturing, strategy development and company transactions. Just before joining CordenPharma, Jason had been Vice President of company developing & technique for Dishman. Jason holds a B.S. in Chemistry plus an MBA from Fairleigh Dickinson University.
Dr. Stephen Houldsworth VP, Global Mind of Platform Management & Advertising, CordenPharma Overseas
Dr. Stephen Houldsworth is the VP, worldwide mind of system Management & advertising. With more than two decades when you look at the CDMO industry, Stephen joined CordenPharma in 2017 as Director, international Small Molecules & Antibiotics Platforms. ebonyflirt Ahead of joining CordenPharma Stephen held different senior roles in R&D, production, Operations, company developing and product product Sales in Dalton Pharma Services & most recently Apotex Pharmachem. Stephen includes a Ph.D. in natural chemistry through the University of Nottingham (UK) where he carried out research when you look at the band of Prof. G. Pattenden, accompanied by a postdoctoral remain in the band of V. Snieckus in the University of Waterloo (CA).